NoteMechanism of fluid infusion during microneedle insertion and retraction
Introduction
Microneedles have been proposed as a novel drug delivery method that can capture the convenience of a transdermal patch and the efficacy of a hypodermic needle [1], [2]. These microscopic needles have been fabricated by adapting the tools of the microelectronics industry to penetrate typically hundreds of microns into the skin in a painless manner. Solid microneedles have been used to pierce the skin, after which a patch can be applied for passive or iontophoretic delivery across permeablized skin [3], [4], [5]. Solid microneedles have also been coated with drugs, proteins, DNA and vaccines for rapid dissolution within the skin [6], [7].
Drug delivery by injection through hollow microneedles has been demonstrated to deliver small (∼ 10 μl) quantities of insulin to animal models [8], [9] and even smaller quantities (1 μl) of methyl nicotinate to human subjects [10]. Achieving larger flow rates has been difficult, apparently due to low flow conductivity in the skin. To determine what limits flow into the skin from microneedles, we recently tested the hypothesis that infusion through hollow microneedles into the skin is limited by the resistance to flow offered by the dense dermal tissue compressed during microneedle insertion [11]. Consistent with this hypothesis, our previous study showed that by first inserting microneedles into the skin and then partially retracting before infusing fluid increased infusion flow rate by up to more than a factor of 10. Microneedle retraction similarly increased infusion of an insulin solution to diabetic rats in vivo [12]. In this study, we seek to further test this hypothesis and in particular determine what happens to the skin microstructure during microneedle insertion and retraction.
Section snippets
Materials and methods
The materials and methods used in this study have been described previously [11]. In brief, single glass microneedles were fabricated with an effective tip opening radius of 30 μm and a tip bevel angle of 38°. Microneedles were inserted into human cadaver abdominal skin (Emory University Body Donor Program, Atlanta, GA, obtained with approval from the Georgia Institute of Technology IRB), which had been stored at − 80 °C, warmed to room temperature, hydrated, cut into 4 × 4 cm pieces, and
Results
Our previous study tested the hypothesis that infusion through hollow microneedles into the skin is limited by the resistance to flow offered by dense dermal tissue compressed during microneedle insertion [11]. Consistent with this hypothesis, partial microneedle retraction out of the skin following needle insertion should relieve tissue compaction and thereby increase infusion into the skin. Indeed, insertion of a microneedle to a depth of 1080 μm without retraction resulted in very little
Discussion
Injection or infusion into the skin using hollow microneedles is an attractive drug delivery method, but has been difficult to achieve at large flow rates. This study provides an explanation for why infusion through microneedles is difficult, as well as strategies to overcome these difficulties. Because skin is elastic, needle insertion is associated with tissue deformation. The resulting skin compaction locally reduces flow conductivity and thereby makes infusion difficult. This explains why
Conclusion
This study supports the hypothesis that infusion through hollow microneedles into the skin is limited by the resistance to flow offered by dense dermal tissue compressed during microneedle insertion. In vitro microscopy studies showed that during microneedle insertion, most needle displacement caused skin indentation, while only a small fraction (i.e., 10–30%) of needle displacement was associated with penetration into the skin. This skin indentation locally compressed the skin, which is
Acknowledgements
We would like to thank Susan Brooks and the Emory University Body Donor Program for providing the human cadaver skin and Harvinder Gill for the helpful technical discussions. WM, JSM and MRP are members of the Georgia Tech Center for Drug Design, Development and Delivery. This work was supported in part by the National Institutes of Health.
References (18)
Microneedles for transdermal drug delivery
Adv. Drug Deliv. Rev.
(2004)- et al.
Microfabricated microneedles: a novel method to increase transdermal drug delivery
J. Pharm. Sci.
(1998) - et al.
Transdermal delivery of desmopressin using a coated microneedle array patch system
J. Control. Release
(2004) - et al.
Insertion of microneedles into skin: measurement and prediction of insertion force and needle fracture force
J. Biomech.
(2004) - et al.
Age and the chemical constitution of normal human dermis
J. Invest. Dermatol.
(1972) - et al.
Flow conductivity of rat dermis is determined by hydration
Biorheology
(1995) - et al.
Microneedles
- et al.
Transdermal delivery of antisense oligonucleotides with microprojection patch (Macroflux) technology
Pharm. Res.
(2001) - et al.
Microfabricated silicon microneedles for nonviral cutaneous gene delivery
Br. J. Dermatol.
(2004)